Literature DB >> 8996652

Risk factors of sensorineural hearing loss in preterm infants.

C Borradori1, C L Fawer, T Buclin, A Calame.   

Abstract

Among 547 preterm infants of < or = 34 weeks gestation born between 1987 and 1991, 8 children (1.46%) developed severe progressive and bilateral sensorineural hearing loss. Perinatal risk factors of infants with hearing loss were compared with those of two control groups matched for gestation and birth weight and for perinatal complications. Our observations demonstrated an association of hearing loss with a higher incidence of perinatal complications. Ototoxicity appeared closely related to a prolonged administration and higher total dose of ototoxic drugs, particularly aminoglycosides and furosemide. Finally, we strongly recommend to prospectively and regularly perform audiologic assessment in sick preterm children as hearing loss is of delayed onset and in most cases bilateral and severe.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996652     DOI: 10.1159/000244391

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  17 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Therapeutic drug monitoring of aminoglycosides in neonates.

Authors:  Matthijs de Hoog; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

3.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

4.  Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.

Authors:  Aline Fuchs; Monia Guidi; Eric Giannoni; Dominique Werner; Thierry Buclin; Nicolas Widmer; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

Review 5.  Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

6.  Intermittent administration of furosemide or continuous infusion in critically ill infants and children: does it make a difference?

Authors:  J Klinge
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

7.  Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening.

Authors:  D Ari-Even Roth; M Hildesheimer; A Maayan-Metzger; C Muchnik; A Hamburger; R Mazkeret; J Kuint
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03-10       Impact factor: 5.747

8.  Prevalence and risk factors for sensorineural hearing loss: Western Sicily overview.

Authors:  Pietro Salvago; Enrico Martines; Francesco Martines
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-10       Impact factor: 2.503

9.  Excessive exposure of sick neonates to sound during transport.

Authors:  L Buckland; N Austin; A Jackson; T Inder
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

10.  A non-comparative descriptive study of the risk factors for childhood disability, and the rehabilitation services in jeddah, saudi arabia.

Authors:  S Shawky; B A Abalkhail; N K Soliman; M N Kordi
Journal:  J Family Community Med       Date:  2001-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.